Evaluation of a hybrid antimicrobial restriction process at a large academic medical center

Antimicrob Steward Healthc Epidemiol. 2021 Oct 21;1(1):e34. doi: 10.1017/ash.2021.188. eCollection 2021.

Abstract

We conducted a retrospective review of a hybrid antimicrobial restriction process demonstrating adherence to appropriate use criteria in 72% of provisional-only orders, in 100% of provisional orders followed by ID orders, and in 97% of ID-initiated orders. Therapy interruptions occurred in 24% of provisional orders followed by ID orders.